Page last updated: 2024-09-03

sch 42495 and Cardiovascular Stroke

sch 42495 has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balding, LC; Burrell, LM; Farina, NK; Johnston, CI	1

Other Studies

1 other study(ies) available for sch 42495 and Cardiovascular Stroke

Article	Year
Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiovascular System; Disease Models, Animal; Female; Heart Failure; Hormones; Kidney; Methionine; Myocardial Infarction; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Water	2000

Article

Year

Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.

Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:6

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiovascular System; Disease Models, Animal; Female; Heart Failure; Hormones; Kidney; Methionine; Myocardial Infarction; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Water

2000